Citation: | XIE Wen-jun, CHEN Heng, FENG Jing, . Vaccination-related contamination-induced false positive SARS-CoV-2 specimen from a suspected COVID-19 case in Chengdu city: a gene tracing-based analysis[J]. Chinese Journal of Public Health, 2022, 38(8): 996-1000. doi: 10.11847/zgggws1137810 |
[1] |
Bhat EA, Khan J, Sajjad N, et al. SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis – an updated review[J]. Int Immunopharmacol, 2021, 95: 107493. doi: 10.1016/j.intimp.2021.107493
|
[2] |
World Health Organization. WHO coronavirus (COVID-19) dashboard[EB/OL]. (2021 – 08 – 09) [2021 – 08 – 10].https://covid19.who.int/table.
|
[3] |
World Health Organization. Draft landscape and tracker of COVID-19 candidate vaccines[EB/OL]. (2021 – 08 – 09) [2021 – 08 – 10].https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
|
[4] |
中华人民共和国国家卫生健康委员会. 新冠病毒疫苗接种情况[EB/OL]. (2021 – 08 – 10) [2021 – 08 – 10]. http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml.
|
[5] |
中华人民共和国国家卫生健康委员会. 关于印发新型冠状病毒肺炎防控方案(第七版)的通知[EB/OL]. (2020 – 09 – 15) [2020 – 05 – 10]. http://www.nhc.gov.cn/jkj/s3577/202009/318683cbfaee4191aee29cd774b19d8d.shtml.
|
[6] |
常宇桐, 刘丽娟, 张丽萍, 等. 变异新冠病毒对口岸疫情防控影响的快速风险评估[J]. 中国国境卫生检疫杂志, 2021, 44(5): 324 – 326.
|
[7] |
Nextstrain. Genomic epidemiology of SARS-CoV-2[EB/OL]. (2021 – 08 – 10)[2021 – 08 – 10].https://nextstrain.org/ncov/gisaid/global.
|
[8] |
Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England[J]. Science, 2021, 372(6538): eabg3055. doi: 10.1126/science.abg3055
|
[9] |
Faria NR, Mellan TA, Whittaker C, et al. Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil[J]. Science, 2021, 372(6544): 815 – 821. doi: 10.1126/science.abh2644
|
[10] |
Wang PF, Nair MS, Liu LH, et al. Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7[J]. Nature, 2021, 593(7857): 130 – 135. doi: 10.1038/s41586-021-03398-2
|
[11] |
黄雪飞, 吕子彦, 边原, 等. 新型冠状病毒疫苗安全性与有效性研究进展[J]. 医药导报, 2021, 40(7): 851 – 856.
|
[12] |
Wang GL, Wang ZY, Duan LJ, et al. Susceptibility of circulating SARS-CoV-2 variants to neutralization[J]. N Engl J Med, 2021, 384(24): 2354 – 2356. doi: 10.1056/NEJMc2103022
|
[13] |
冯晔囡, 宋洋, 王世文, 等. 全球新型冠状病毒变异株研究进展[J]. 病毒学报, 2021, 37(3): 685 – 711.
|
[14] |
中国疾病预防控制中心. 关于新冠疫苗接种单位环境标本监测相关工作技术建议[EB/OL]. (2021 – 01 – 24)[2021 – 05 – 10]. http://www.chinacdc.cn/jkzt/crb/xcrxjb/202101/t20210124_223913.html.
|
[15] |
中华人民共和国国家卫生健康委员会. 关于印发新型冠状病毒肺炎诊疗方案(试行第八版)的通知[EB/OL]. (2020 – 08 – 19) [2020 – 05 – 10]. http://www.nhc.gov.cn/yzygj/s7653p/202008/0a7bdf12bd4b46e5bd28ca7f9a7f5e5a.shtml.
|